ImmunoGen

board

ImmunoGen is a company.

select Filter
All
Business
Culture
Environment
Health
Politics
Research

Key facts

Latest news (see all)

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Read: CNBC News

2023-11-30

AbbVie to Buy ImmunoGen for More Than $10 Billion

Read: The Wall Street Journal

2023-11-30

Metrics

Business

assets 525.8M $
Debt 0 $
free cash flow -97,827,200.00
market cap 1,128,660,000.00

Visualizations

Datasets

Source

This dashboard is based on data from: Twitter, YAHOO-FIN, YFINANCE

Updated: 3 days ago

License

This content can be used under the CC BY 4.0 license

Going further

We would recommend you have a look at connected dashboards:
dark About